Free shipping across India over ₹699 · 10% off your first order with code AORA10Shop the catalog →
A 2026 guide to reading liver support tablet labels in India: FSSAI vs AYUSH, standardised silymarin doses, heavy metal testing, and CYP450 interactions.
The Indian liver support tablet shelf in 2026 holds three different product categories that look identical from the outside. Knowing which one you are buying is the most important label check you will ever do.
Liver support tablets in India fall into three regulatory buckets: FSSAI-licensed nutraceuticals (silymarin, NAC, beetroot), AYUSH-licensed Ayurvedic medicines (kutki, bhumi amla, classical formulations), and prescription hepatoprotectants (UDCA, L-ornithine L-aspartate) that need a doctor. Before you buy any over-the-counter product, check the licence type on the label, look for standardised active content in mg (not just "extract"), confirm heavy metal testing for Ayurvedic items, and review interactions with anything you already take. Tablets do not replace lab follow-up.
The first label check is regulatory, not nutritional. India regulates liver support products under three separate systems and the rules are very different.
**FSSAI nutraceuticals** carry an FSSAI licence number (a 14-digit code starting with 1, 2, or similar) and are governed by the Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use) Regulations, 2022. These contain ingredients with established safety profiles such as silymarin (milk thistle), N-acetylcysteine, beetroot extract, choline, and inositol. They are sold as food supplements and cannot legally claim to treat disease. The 2022 regulations require disclosure of active ingredient quantity, source, and standardisation. FSSAI maintains a public list of permitted ingredients and limits, available at fssai.gov.in.
**AYUSH-licensed Ayurvedic products** carry an AYUSH licence number issued by a state Drug Controller under the Drugs and Cosmetics Act. Common formulations include Liv.52, Livotone, Amalaki Rasayan, and single-herb tablets of kutki (Picrorhiza kurroa) or bhumi amla (Phyllanthus niruri). These can claim therapeutic use within Ayurvedic terminology (yakrit, pitta) but cannot use modern disease language on the pack.
**Prescription hepatoprotectants** are tablets you should not be self-medicating. Ursodeoxycholic acid (UDCA), L-ornithine L-aspartate, S-adenosyl methionine, and metadoxine are Schedule H drugs. If you see these on a label, you are looking at a pharmaceutical product that needs a doctor's prescription, regardless of how the website describes it.
This is where most Indian liver tablet labels lose their integrity. A label that says "milk thistle extract 200 mg" tells you almost nothing useful. The active compound in milk thistle is silymarin, a complex of flavonolignans (silybin, silydianin, silychristin), and the silymarin content of an extract can vary from 20% to 80%.
Look for a label that lists **silymarin content in mg per serving**, not just extract weight. A standardised product will say something like "milk thistle extract 200 mg (standardised to 80% silymarin, providing 160 mg silymarin)". Most clinical trials on silymarin have used doses in the 140 mg to 420 mg silymarin range per day, typically split across two or three servings, as reviewed in a meta-analysis on PubMed. Without standardisation disclosure you cannot tell whether the tablet matches the studied dose or contains a tenth of it.
The same logic applies to other ingredients. Kutki should list picroside I and II content. Bhumi amla extracts vary widely in lignan and tannin content. NAC is one of the few ingredients where mg of the molecule itself is meaningful, since it is a single chemical rather than a plant extract. For our own Silybeet formulation we list silymarin in mg, NAC in mg, and beetroot polyphenol content separately, because the herb name on its own is marketing, not chemistry.
| Feature | FSSAI nutraceutical | AYUSH Ayurvedic | Prescription | |---|---|---|---| | Licence on label | 14-digit FSSAI number | AYUSH number from state Drug Controller | Schedule H, manufacturing licence | | Typical actives | Silymarin, NAC, beetroot, choline | Kutki, bhumi amla, Liv.52 blend | UDCA, LOLA, SAMe, metadoxine | | Standardisation expected | Yes, mg of active compound | Variable, often classical recipe | Pharmaceutical grade | | Heavy metal testing | Required by FSSAI limits | Required by AYUSH GMP, less consistent in practice | Pharmaceutical GMP | | Disease claims allowed | No | Within Ayurvedic terms only | Yes, per approved indication | | Need a prescription | No | No | Yes | | Where to verify licence | fssai.gov.in FoSCoS portal | State AYUSH directorate | CDSCO |
This is a real concern, not a theoretical one. Multiple peer-reviewed studies have found lead, mercury, and cadmium contamination in batches of Ayurvedic products sold both in India and exported to the US. A JAMA study on heavy metal content of Ayurvedic medicines found that around 20% of products sampled contained detectable lead, mercury, or arsenic above the recommended intake limits. Some classical formulations called *rasa* preparations intentionally contain processed metals; many tablet products do not, but contamination from soil, water, or processing equipment is well documented.
The Indian Council of Medical Research and the Ministry of AYUSH require GMP compliance and heavy metal limits for licensed Ayurvedic manufacturers. The practical reality is that compliance varies. Before you buy an Ayurvedic liver tablet, check for: a clearly printed manufacturing licence number, GMP certification (look for "GMP" or "ISO 9001" on the pack), batch number with manufacturing and expiry dates, and ideally a third-party certificate of analysis available on the brand's website. Reputable manufacturers publish heavy metal test reports per batch. If a brand does not, treat that as a meaningful red flag, especially for daily long-term use.
The same caution applies to imported "wildcrafted" herbal products and unbranded loose powders sold by weight. These sit outside the formal licensing system and carry the highest contamination risk.
Many common liver support ingredients interact with the CYP450 enzyme system that metabolises a large fraction of prescription drugs. This matters most if you take medication for blood pressure, cholesterol, diabetes, thyroid, mental health, or seizures.
Silymarin can mildly inhibit CYP3A4 and CYP2C9, which means it can theoretically raise blood levels of statins, certain blood thinners (warfarin), some antidepressants, and tacrolimus. The effect in healthy people at typical supplement doses is modest, as covered in the NIH MedlinePlus monograph on milk thistle, but it is worth flagging to your doctor if you take any of the above. NAC interacts with nitroglycerin and can affect anticoagulant activity. Beetroot raises nitric oxide and can stack with blood pressure medication, dropping pressure further than intended. Picrorhiza and other bitter Ayurvedic herbs can affect glucose handling, which matters if you take metformin or insulin.
The rule that works for most people: bring the tablet bottle to your next prescription review and ask the doctor directly. Do not stop a prescribed medication to make room for a supplement, and do not start a new supplement during a period of dose changes for any chronic medication.
A raised ALT or SGPT result is a signal to investigate, not a prompt to shop. Persistently elevated liver enzymes (ALT above 2x the upper limit for more than three months, or any AST/ALT result above 5x the upper limit) need a proper workup that may include ultrasound, fibroscan, viral hepatitis screening, and a review of medications and alcohol intake. A tablet cannot substitute for that workup, no matter how reassuring the label is.
Specific red flags that mean stop browsing and book a clinic visit: yellowing of skin or eyes (jaundice), persistent right upper abdominal pain, dark urine with pale stools, unexplained weight loss, easy bruising, or confusion. New medication started in the past three months plus rising enzymes is also a hepatology referral, not a supplement question. For context on when testing should drive decisions instead of guessing, our piece on liver enzymes and supplements: why testing beats guessing walks through the order of operations.
If you have decided that a liver support tablet fits your routine, work through this list before you add anything to cart.
For context on what evidence does and does not support, our companion piece on milk thistle for fatty liver: what evidence can and cannot say covers the realistic expectations. If your search started after a heavy weekend, alcohol and supplements: what not to mix after a heavy weekend is the more useful first read. For readers managing both metabolic and liver markers, liver support for PCOS and metabolic health: what not to assume sets the right frame.
Speak with a doctor before starting any liver support tablet if you have jaundice, abnormal LFTs (ALT, AST, ALP, GGT, bilirubin), known hepatitis B or C, autoimmune liver disease, gallstones, pregnancy or breastfeeding, regular prescription medication, or a recent hospital admission. The same applies if you drink alcohol most days, take multiple herbal products, or are on chemotherapy or immunosuppression. A tablet bought from a shelf is not a substitute for a proper hepatology assessment.
Connected guides, ingredient explainers, product context, and tools chosen from this article's topic cluster.
Fatty liver basics, milk thistle, NAC, antioxidants, alcohol recovery
Relevant for liver-support and antioxidant education.
sleep timing mineral support: a practical Aora guide to sleep habits, stress routines, supplement labels, safety cautions, and when to ask a clinician.
bedtime routine India: a practical Aora guide to sleep habits, stress routines, supplement labels, safety cautions, and when to ask a clinician.
Detox teas sell a story your body already runs for free. Here is what they really do to your gut, and what a real gut routine looks like in 2026.
The first label check is regulatory, not nutritional. India regulates liver support products under three separate systems and the rules are very different.
This is where most Indian liver tablet labels lose their integrity. A label that says "milk thistle extract 200 mg" tells you almost nothing useful. The active compound in milk thistle is silymarin, a complex of flavonolignans (silybin, silydianin, silychristin), and the silymarin content of an extract can vary from 20% to 80%.
This is a real concern, not a theoretical one. Multiple peer-reviewed studies have found lead, mercury, and cadmium contamination in batches of Ayurvedic products sold both in India and exported to the US. A JAMA study on heavy metal content of Ayurvedic medicines found that around 20% of products sampled contained detectable lead, mercury, or arsenic above the recommended intake limits. Some classical formulations c
Many common liver support ingredients interact with the CYP450 enzyme system that metabolises a large fraction of prescription drugs. This matters most if you take medication for blood pressure, cholesterol, diabetes, thyroid, mental health, or seizures.
5 linked sources checked against our citation and claim-safety process.
Updated 18 Jun 2026 with supplement-claim and medical-disclaimer boundaries.
Recommended from the Aora range
Read our full medical disclaimer and editorial policy.
Supplement content is educational only and should not replace medical advice from a qualified clinician. Product mentions are reviewed for claim safety before publication.
